40
Participants
Start Date
July 16, 2020
Primary Completion Date
July 15, 2023
Study Completion Date
July 15, 2023
dupilumab
Pre-filled syringe administered by subcutaneous (SC) injections
Matching placebo
Pre-filled syringe administered by subcutaneous (SC)
Regeneron Study Site, Berlin
Temple University Hospital, Philadelphia
CHU Dijon, Dijon
Regeneron Study Site, Großhansdorf
Hospital General Universitario Gregorio Maranon (HGUGM) - Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Madrid
American Health Research, Charlotte
Regeneron Study Site, Hanover
Regeneron Study Site, Hendersonville
UH Cleveland Medical Center, Cleveland
University of Michigan, Ann Arbor
CHU Reims, Reims
University of Iowa Hospitals & Clinics-Roy J. and Lucille A. Carver College of Medicine, Iowa City
IKF Pneumologie Mainz, Helix Medical Excellence Center Mainz, Mainz
Regeneron Study Site, Koblenz
Regeneron Study Site, Frankfurt am Main
IKF Pneumologie GmbH & Co. KG - Institut fuer klinische Forschung Pneumologie Frankfurt (Clinical Research Centre Respiratory Medicine) to IKF Pneumologie Frankfurt GmbH & Co KG., Frankfurt am Main
Praxis Dr. M. Rolke u. Dr. P. Rueckert, Aschaffenburg
University Of Kansas Medical Center, Kansas City
CHU de Strasbourg - Nouvel Hopital Civil, Strasbourg
The University of Texas Medical School at Houston, Houston
Intermountain Medical Center, Murray
Palos Verdes Medical Group (PVMG); Peninsula Research Associates (PRA), Rolling Hills Estates
UCLA Medical Center - Harbor, Torrance
Allianz Research Institute, Westminster
KLB - Gesundheitsforschung Luebeck GmbH, Lübeck
Infinity Medical Research, North Dartmouth
Regeneron Study Site, Lubin
Centrum Medycyny Oddechowej, Mroz Spolka Jawna, Bialystok
Lekarze Specjalisci - J. Malolepszy i Partnerzy, Wroclaw
Hospital Universitario de Bellvitge, Barcelona
Regeneron Pharmaceuticals
INDUSTRY